Skip to main
Ulysseus Science
Communities
My dashboard
New upload
New community
Log in

G

C

GOBBI , Claudio

Last name: GOBBI

First name: Claudio

    Recent uploads

  • 2021 (v1)
    Publication
    Metadata-only
    Recurrence and Prognostic Value of Asymptomatic Spinal Cord Lesions in Multiple Sclerosis
    Ostini, Camilla Bovis, Francesca Disanto, Giulio

    Spinal magnetic resonance imaging (MRI) is currently not recommended for the routine monitoring of clinically stable multiple sclerosis (MS) patients. We aimed to investigate the occurrence of asymptomatic spinal lesions (a-SL) in clinically stable MS patients, and their association with clinical and radiological outcomes, including the...

    Uploaded on: April 14, 2023
  • 2024 (v1)
    Publication
    Metadata-only
    Biometry extraction and probabilistic anatomical atlas of the anterior Visual Pathway using dedicated high-resolution 3-D MRI
    Pravatà, Emanuele Diociasi, Andrea Navarra, Riccardo

    : Anterior Visual Pathway (aVP) damage may be linked to diverse inflammatory, degenerative and/or vascular conditions. Currently however, a standardized methodological framework for extracting MRI biomarkers of the aVP is not available. We used high-resolution, 3-D MRI data to generate a probabilistic anatomical atlas of the normal aVP and its...

    Uploaded on: February 16, 2024
  • 2024 (v1)
    Publication
    Metadata-only
    Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)
    Schiavetti, Irene Signori, Alessio Albanese, Angela

    Background and purpose: Cladribine tablets, a purine analogue antimetabolite, offer a unique treatment regimen, involving short courses at the start of the first and second year, with no further treatment needed in years 3 and 4. However, comprehensive evidence regarding patient outcomes beyond the initial 24 months of cladribine treatment is...

    Uploaded on: October 25, 2024

About Ulysseus

Main website

Join our research network

Match4Cooperation

Powered by InvenioRDM